Real-world use of Permixon® in benign prostatic hyperplasia--determining appropriate monotherapy and combination treatment.
about
Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system.Promising molecular targets and biomarkers for male BPH and LUTSEffect ofSerenoa Repenson Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia
P2860
Real-world use of Permixon® in benign prostatic hyperplasia--determining appropriate monotherapy and combination treatment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Real-world use of Permixon® in ...... apy and combination treatment.
@en
Real-world use of Permixon® in ...... apy and combination treatment.
@nl
type
label
Real-world use of Permixon® in ...... apy and combination treatment.
@en
Real-world use of Permixon® in ...... apy and combination treatment.
@nl
prefLabel
Real-world use of Permixon® in ...... apy and combination treatment.
@en
Real-world use of Permixon® in ...... apy and combination treatment.
@nl
P2093
P2860
P1433
P1476
Real-world use of Permixon® in ...... apy and combination treatment.
@en
P2093
Andrew Gillon
Gary Milligan
Maren White
Peter Anderson
Richard Perry
P2860
P2888
P304
P356
10.1007/S12325-012-0024-X
P407
P577
2012-05-25T00:00:00Z